1. $MRK :http://www.noodls.com/view/A40D30CE655B87F9704A1E365986CF53FA475D87

  2. MA10-MA50 Bull Crossover Stocks (Apr. 24): $CSCO, $CSX, $CVC, $MRK, $WEC http://www.ninestocks.com/2015/04/ma10-ma50-bull-crossover-stocks-apr-24-2/

  3. Could Merck & Co, Inc. u2019s ($MRK) Hep C Drugs Be A Threat To Gilead Sciences, Inc. ($GILD) & AbbVie Inc ($ABBV)? http://www.bidnessetc.com/40979-could-merck-co-incs-mrk-hepatitis-c-drugs-be-a-threat-to-gilead-sciences-i/

  4. $AGEN Investors bringing up possibility of #Agenus going to triple digits. QS-21 undisclosed programs, $MRK/$INCY partnerships could = 20x.

  5. Trying to digest all the EASL data--doesn t seem like anything really new presented. Did I miss something?? $GILD $ABBV $ACHN $MRK $BMY

  6. DIJA Earnings Previews for This Week: Apple, Merck, Pfizer, Exxon, Visa, Chevron $AAPL $MRK $PFE $XOM $V $CVX http://247wallst.com/investing/2015/04/26/7-dija-earnings-previews-for-this-week-apple-merck-pfizer-exxon-visa-chevron/

  7. DIJA Earnings Previews for This Week http://10xtradingsignals.com/2015/04/26/7-dija-earnings-previews-for-this-week/ $AAPL $MRK $PFE $XOM $V $CVX

  8. $GWPH -5% coming next week. $PFE and $MRK will crush them!!!!

  9. MRK - Technical analysis trend $MRK http://lssinvest.blogspot.pt/2015/04/mrk-technical-analysis-trend_25.html

  10. $ABBV http://seekingalpha.com/news/2454176-preliminary-data-show-100-percent-svr4-for-viekirax-exviera $GILD $MRK

  11. $ABBV 100% SVR4 rate for Viekirax+Exviera. Good luck $GILD $MRK

  12. $GILD Any news on the HepB or NASH front? It sounded like $MRK had decent results from the hepc trials..

  13. 9. $ENZN went through strategic review 2 years ago. Conclusion was dividends best. Its not getting bought by $MRK

  14. The Parade Of Weak Earnings Reports Continues $XOM $VIAB $UPS $PFE $MRK $MA $IP $GILD $F $ETN $CVX $CVS http://www.talkmarkets.com/content/stocks--equities/the-parade-of-weak-earnings-reports-continues?post=63619

  15. End Of Day Scan: Elder Bar Blue $HAL $IWM $RAD $KO $YHOO $XLV $SFUN $GILD $SUNE $MRK

  16. Covestor holds an allocation of 0.4% in $MRK in his Risk Protection Investment Portfolio

  17. Big bio/healthcare companies $JNJ $GSK $MRK $INCY have partnerships with $AGEN

  18. Earnings train slowing down. But not stopping yet. Results next week from $AAPL $F $UPS $PFE $MRK $TMUS $TWTR $FCAU $TWX $XOM $GILD $V $CVS.

  19. $MRK reports crappy data on their combo and $GILD drops. Manipulation for sure...

  20. Today s Top Performers In Drugs $MRK http://www.thestreet.com/story/13125906/1/todays-top-performers-in-drugs.html?puc=stocktwits&cm_ven=STOCKTWITS&utm_source=dlvr.it&utm_medium=organic&utm_campaign=stocktwits

  21. $PFE vs. $ABBV vs. $ACT vs. $MRK Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=PFE|ABBV|ACT|MRK|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  22. $MRK BofA #EASL15: Updates from $GILD, $ICPT, and competitors..... http://bridgetunnelinvestor.freeforums.net/thread/1119/easl15?page=1&scrollTo=5824

  23. Morgan Stanley alert: Gilead investors don t have the whole story $GILD $MRK http://www.benzinga.com/analyst-ratings/analyst-color/15/04/5440630/morgan-stanley-alert-gilead-investors-dont-have-the-whol

  24. $ABBV Viekira turned out to be a dud; no sales outside $ESRX. $MRK will displace ABBV in 2016 and $GILD remains undisputed leader in Hepc.

  25. @LockStockAnd $MRK Fantastic news!! Merck Melanoma Drug u2019s Success in Lung Cancer. http://www.bloomberg.com/news/articles/2015-04-20/test-may-show-merck-melanoma-drug-s-success-in-lung-cancer?cmpid=yhoo